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Summary
Treatment of porcine kidney (PK-15) cells with
either interferon-gamma (IFN-g) or endosomal-
lysosomal system acidification inhibitors increases
replication of porcine circovirus type 2 (PCV2). In
the present study, the effect of a combination of
these treatments on the number of infected cells
and virus yield was tested. The number of PCV2
(Stoon-1010)-infected PK-15 cells increased in
cells treated with ammonium chloride (445 39%
increase), IFN-g (446 8%), ammonium chlorideþ
IFN-g (1721  283%), chloroquine diphosphate
(1037  121%), chloroquine diphosphateþ IFN-g
(2199  255%), monensin (950  178%) and
monensinþ IFN-g (1948 60%). Combined IFN-
g and endosomal-lysosomal system acidification
inhibitors increased PCV2 yield by up to 50 times
compared to untreated PK-15. This augmented vi-
rus replication in PK-15 cells may be helpful in the
production of PCV2 vaccines.

Porcine circovirus type 2 (PCV2) is a member
of the genus Circovirus, family Circoviridae [30].
PCV2 infections are mainly associated with a mul-
tifactorial disease in pigs, postweaning multisyste-
mic wasting syndrome (PMWS) [1, 7, 9, 12, 17,
27]. Apart from PMWS, PCV2 has also been as-
sociated with various disease syndromes in pigs
including porcine dermatitis and nephropathy syn-
drome [3, 5, 19, 21, 31, 35, 37], congenital tremors
[6, 14], reproductive failure [16, 18, 21, 28, 29,
33], exudative epidermitis [38], porcine respiratory
disease complex [13], proliferative and necrotizing
pneumonia [11] and enteritis [4, 15]. In vitro, PCV2
replicates in porcine kidney epithelial cells [2, 20,
25, 32], and PCV2 isolation and production is
routinely performed using porcine kidney (PK-15)
and swine kidney (SK) epithelial cell lines [2, 32].
When PCV2 replication kinetics were studied in a
PK-15 epithelial cell line that was inoculated with
the prototype PCV2 strain Stoon-1010 [9], 1.8% of
cells were infected with a maximum yield of 3.9
log10 TCID50=ml in culture supernatant [22]. This
low yield slows down the production of PCV2
vaccines. Therefore, increasing the replication of
PCV2 in PK-15 cells will allow vaccine production
to be scaled up, making the production more effi-
cient and profitable.
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Earlier studies have shown that the number of
PCV2-infected cells can be enhanced by treatment
of PK-15 cells either with interferon-gamma (IFN-g)
[23] or inhibitors of endosomal-lysosomal system
acidification such as ammonium chloride (NH4Cl),
chloroquine diphosphate (CQ) and monensin [25].
In the study by Meerts et al. [23], the effect of IFN-
g treatment of PK-15 cells on the PCV2 yield was
also investigated, and it was shown that IFN-g
treatment increased the yield of progeny PCV2 by
20 times. Up till now, neither the effect of treatment
of PK-15 cells with the endosomal-lysosomal sys-
tem acidification inhibitors alone nor the effect of
treatment of PK-15 cells with the combination of
IFN-g and inhibitors of the endosomal-lysosomal
system acidification on PCV2 yield have been in-
vestigated. It was the aim of the present study to
investigate the combined effect of treating PK-15
cells with IFN-g and inhibitors of endosomal-lyso-
somal system acidification on PCV2 infection and
PCV2 yield.
To investigate the effect of IFN-g and inhibitors
of the endosomal-lysosomal system acidification
on the number of PCV2-infected cells, 2104
PK-15 cells that were free of porcine circoviruses
were seeded per well of a 96-well cell culture plate
(Nunc, Roskilde, Denmark). Cells were maintained
at 37 C in a humidified 5% CO2 incubator in cul-
ture medium containing 10% fetal bovine serum
(FBS; Invitrogen, Grand Island, U.S.A.), 0.3 mg=ml
L-glutamine (BDH Chemicals Ltd., Poole, England),
1% nonessential amino acids (100 ; Invitrogen),
1 mM sodium pyruvate (Invitrogen), 100 U=ml
penicillin, 0.1 mg=ml streptomycin and 0.1 mg=ml
kanamycin in RPMI-1640 (Invitrogen). Recombi-
nant porcine IFN-g (R & D systems, Abingdon,
U.K.) was dissolved and stored as previously de-
scribed [23]. Cell culture medium with or without
500 U=ml IFN-g was added to PK-15 cells at
6 h post-seeding. At 24 h post-seeding, cells were
washed and inoculated with prototype PCV2 strain
Stoon-1010 (5.3 log10 TCID50, 20
th passage) at a
Fig. 1. Effect of IFN-g and in-
hibitors of endosomal-lysosomal
system acidification on PCV2 in-
fection of PK-15 cells. Representa-
tive light microscopic images of
PK-15 cells treated with or without
IFN-g and=or CQ after performing
an IPMA staining to identify
PCV2-infected cells. Bar: 200mm
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multiplicity of infection (moi) of 0.3 at 37 C. After
1 h, the viral inoculum was washed off and cells
were incubated in cell culture medium with or
without 25 mM, 125 mM or 6mM of NH4Cl, CQ
or monensin, respectively. At 24 h post-inoculation
(hpi), cell culture medium with or without the en-
dosomal-lysosomal system inhibitors was replaced
with fresh cell culture medium without inhibitors
of endosomal-lysosomal system acidification. Cells
were fixed with methanol at 20 C for 10 min af-
ter the first cycle of PCV2 replication at 36 hpi [22].
PCV2-infected cells were identified by an immuno-
peroxidase monolayer assay (IPMA) using porcine
polyclonal anti-PCV2 antibodies [34] and horserad-
ish peroxidase-conjugated polyclonal rabbit anti-
swine immunoglobulins (DakoCytomation, Glostrup,
Denmark). Substrate was added to stain-infected
cells, which were then counted by examination
under a light microscope (Olympus Optical Co.,
Hamburg, Germany). The number of infected cells
per well in untreated PK-15 cells was used as a
reference, and all results were expressed as relative
percentages to this reference. All experiments were
performed three times with each condition in a sin-
gle experiment in quadruplicate.
Treatment of PK-15 cells either with IFN-g or
inhibitors of endosomal-lysosomal system acidifi-
cation increased the number of PCV2-infected cells
(Figs. 1 and 2), in agreement with previous studies
[23, 25]. Combined treatment of PK-15 cells with
IFN-g and inhibitors of endosomal-lysosomal sys-
tem acidification also increased the number of
PCV2-infected cells. The percentages of PCV2-
infected PK-15 cells at 36 hpi in untreated and treat-
ed PK-15 cells are shown in Table 1. From these
results, it can be concluded that inhibiting endo-
somal-lysosomal system acidification gives an ad-
ditional enhancement of PCV2 infection in PK-15
cells treated with IFN-g. This additional effect was
possible because IFN-g and inhibitors of endoso-
Fig. 2. The effect of IFN-g and inhibitors of endosomal-
lysosomal system acidification on the number of PCV2-
infected PK-15 cells. PK-15 cells were pre-treated with
(filled bars) or without (empty bars) IFN-g before they were
inoculated with PCV2. After PCV2 inoculation, cells were
incubated with or without inhibitors of endosomal-lysosom-
al system acidification for 24 h. Cells were fixed at 36 hpi
and PCV2-infected cells were counted following IPMA
staining. The number of PCV2-infected cells in untreated
cell cultures was taken as reference, and all values are re-
lative percentages of this reference
Table 1. Total PCV2 yield in untreated PK-15 cells and PK-15 cells treated with IFN-g, inhibitors of endosomal-lysosomal
system acidification, or a combination of IFN-g and inhibitors of endosomal-lysosomal system acidification
Lysosomotropic
agent
IFN-g (U=ml) % of PCV2-infected
cells at 36 hpi
PCV2 titre log10 (TCID50 per 10
5 cells)
1 hpi 24 hpi 48 hpi 72 hpi
Control 0 0.38  0.03 1.9 1.5 2.9 3.1
Control 500 1.71  0.12 2.0 2.1 3.4 3.9
NH4Cl 0 1.70  0.06 2.1 1.9 3.0 3.8
NH4Cl 500 6.67  1.57 1.6 3.0 4.0 4.8
CQ 0 3.97  0.31 1.4 1.8 3.3 4.3
CQ 500 8.47  1.23 1.6 2.3 4.0 4.6
Monensin 0 3.61  0.39 1.9 2.3 3.9 3.6
Monensin 500 7.52  1.17 2.0 2.8 4.6 4.8
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mal-lysosomal system acidification are known to
affect different stages of PCV2 infection. Previous
studies have shown that treatment of cells with
IFN-g increases PCV2 infection by increasing in-
ternalization of PCV2 particles into the cell [23],
while treatment of cells with inhibitors of the en-
dosomal-lysosomal system acidification increases
PCV2 infection by increasing disassembly of inter-
nalized PCV2 particles within the cell [25].
For virus yield assays, 2105 cells were seeded
per well of a 24-well cell culture plate (Nunc).
Cells were pre-treated with or without 500 U=ml
IFN-g at 6 h post-seeding. At 24 h post-seeding,
cells were washed and inoculated with the proto-
type PCV2 strain Stoon-1010 (5.3 log10 TCID50,
20th passage) at an moi of 0.3 for 1 h at 37 C.
The viral inoculum was washed off, and cells were
further incubated in culture medium with or with-
out 25 mM NH4Cl, 125 mM CQ or 6mM monensin
for 24 h. Then, the culture medium with or with-
out endosomal-lysosomal system acidification in-
hibitors was replaced with fresh culture medium
without inhibitors of endosomal-lysosomal system
acidification. All inhibitors of endosomal-lysosom-
al system acidification were removed at 24 hpi be-
cause one of the inhibitors, monensin, is a classical
exocytosis blocker [8, 10, 26, 36]. At 1, 24, 48 and
72 hpi, the cell culture supernatant was collected.
Cells were subjected to three freeze-thaw cycles.
Total virus yield (intra- and extracellular virus titres)
was determined on PCV2-negative PK-15 cells
by inoculation of a tenfold dilution series on PK-
15 cells in quadruplicate, as previously described
[24]. After 36 h of cultivation at 37 C in the pres-
ence of 5% CO2, cells were fixed in methanol at
20 C for 10 min. Viral antigens were detected
using an IPMA as described above, and PCV2 titres
were expressed as log10 TCID50 per 10
5 cells.
Treatment of PK-15 cells either with IFN-g or
inhibitors of endosomal-lysosomal system acidifi-
cation increased PCV2 yield (Table 1). Combined
treatment of PK-15 cells with IFN-g and inhibitors
of endosomal-lysosomal system acidification fur-
ther increased PCV2 yield. PCV2 yield increased
gradually under all conditions, with the highest yield
observed at 72 hpi. The highest recorded PCV2
yield was 4.8 log10 TCID50 per 10
5 treated cells
compared to 3.1 log10 TCID50 per 10
5 untreated
cells at 72 hpi. This is a 50-fold increase in PCV2
yield. The highest increase in PCV2 infection was
observed when PK-15 cells were treated with a
combination of IFN-g and CQ or NH4Cl.
The results of the present study show that a com-
bined inhibition of endosomal-lysosomal system
acidification and IFN-g treatment of PK-15 cells
increases the number of PCV2-infected cells and
PCV2 yield. Treatment of cells with a combination
of inhibitors of endosomal-lysosomal system acidi-
fication and IFN-g may be of use in increasing the
yield of PCV2 for PCV2 vaccine production.
Acknowledgments
The authors are grateful to Carine Boone and Chris Bracke
for their skillful technical assistance. This work was funded
by the European Union (Sixth Framework Programme,
Project No. 513928, coordinated by G. Allan). G.M. was
supported with a scholarship for candidates from developing
countries from the Special Research Fund (BOF) of Ghent
University. P.L.D. was supported with a fellowship (B=
06524) from BOF of Ghent University.
References
1. Allan GM, McNeilly F, Kennedy S, Daft B, Clarke EG,
Ellis JA, Haines DM, Meehan BM, Adair BM (1998)
Isolation of porcine circovirus-like viruses from pigs
with a wasting disease in the USA and Europe. J Vet
Diagn Invest 10: 3–10
2. Allan GM, Mc Neilly F, Meehan BM, Kennedy S,
Mackie DP, Ellis JA, Clark EG, Espuna E, Saubi N,
Riera P, Botner A, Charreyre CE (1999) Isolation and
characterisation of circoviruses from pigs with wasting
syndromes in Spain, Denmark and Northern Ireland. Vet
Microbiol 66: 115–123
3. Allan GM, McNeilly E, Kennedy S, Meehan B, Moffett
D, Malone F, Ellis J, Krakowka S (2000) PCV-2-asso-
ciated PDNS in Northern Ireland in 1990. Porcine
dermatitis and nephropathy syndrome. Vet Rec 146:
711–712
4. Chae C (2005) A review of porcine circovirus 2-associ-
ated syndromes and diseases. Vet J 169: 326–336
5. Choi C, Chae C (2001) Colocalization of porcine re-
productive and respiratory syndrome virus and porcine
circovirus 2 in porcine dermatitis and nephrology syn-
drome by double-labeling technique. Vet Pathol 38:
436–441
6. Choi J, Stevenson GW, Kiupel M, Harrach B,
Anothayanontha L, Kanitz CL, Mittal SK (2002)
340 G. Misinzo et al.
Sequence analysis of old and new strains of porcine
circovirus associated with congenital tremors in pigs
and their comparison with strains involved with post-
weaning multisystemic wasting syndrome. Can J Vet
Res 66: 217–224
7. Clark EG (1997) Post-weaning multisystemic wasting
syndrome. Proc Am Assoc Swine Pract 28: 490–501
8. Dinter A, Berger EG (1998) Golgi-disturbing agents.
Histochem Cell Biol 109: 571–590
9. Ellis J, Hassard L, Clark E, Harding J, Allan G, Willson
P, Strokappe J, Martin K, McNeilly F, Meehan B, Todd
D, Haines D (1998) Isolation of circovirus from lesions
of pigs with postweaning multisystemic wasting syn-
drome. Can Vet J 39: 44–51
10. Griffiths G, Quinn P, Warren G (1983) Dissection of the
Golgi complex. I. Monensin inhibits the transport of
viral membrane proteins from medial to trans Golgi
cisternae in baby hamster kidney cells infected with
Semliki Forest virus. J Cell Biol 96: 835–850
11. Harding JC (2004) The clinical expression and
emergence of porcine circovirus 2. Vet Microbiol 98:
131–135
12. Harding JCS, Clark EG, Strokappe JH, Wilson PI, Ellis
JA (1998) Postweaning multisystemic wasting syn-
drome: epidemiology and clinical presentation. Swine
Health Prod 6: 249–254
13. Harms PA, Halbur PG, Sorden SD (2002) Three cases
of porcine respiratory disease complex associated with
porcine circovirus type 2 infection. J Swine Health Prod
10: 27–30
14. Hines RK, Lukert PD (1994) Porcine circovirus as a
cause of congenital tremors in newborn pigs. Proc.
Amer. Assoc. Swine Pract., pp 344–345
15. Kim J, Ha Y, Jung K, Choi C, Chae C (2004) Enteritis
associated with porcine circovirus 2 in pigs. Can J Vet
Res 68: 218–221
16. Kim J, Jung K, Chae C (2004) Prevalence of porcine
circovirus type 2 in aborted fetuses and stillborn piglets.
Vet Rec 155: 489–492
17. Kiupel M, Stevenson GW, Mittal SK, Clark EG, Haines
DM (1998) Circovirus-like viral associated disease in
weaned pigs in Indiana. Vet Pathol 35: 303–307
18. Ladekjaer-Mikkelsen AS, Nielsen J, Storgaard T,
Botner A, Allan G, McNeilly F (2001) Transplacental
infection with PCV-2 associated with reproductive fail-
ure in a gilt. Vet Rec 148: 759–760
19. Larochelle R, Magar R, D’Allaire S (2002) Genetic
characterization and phylogenetic analysis of porcine
circovirus type 2 (PCV2) strains from cases presenting
various clinical conditions. Virus Res 90: 101–112
20. Meehan BM, McNeilly F, Todd D, Kennedy S, Jewhurst
VA, Ellis JA, Hassard LE, Clark EG, Haines DM, Allan
GM (1998) Characterization of novel circovirus DNAs
associated with wasting syndromes in pigs. J Gen Virol
79 (Pt 9): 2171–2179
21. Meehan BM, McNeilly F, McNair I, Walker I, Ellis JA,
Krakowka S, Allan GM (2001) Isolation and charac-
terization of porcine circovirus 2 from cases of sow
abortion and porcine dermatitis and nephropathy syn-
drome. Arch Virol 146: 835–842
22. Meerts P, Misinzo G, McNeilly F, Nauwynck HJ (2005)
Replication kinetics of different porcine circovirus 2
strains in PK-15 cells, fetal cardiomyocytes and macro-
phages. Arch Virol 150: 427–441
23. Meerts P, Misinzo G, Nauwynck HJ (2005) Enhance-
ment of porcine circovirus 2 replication in porcine cell
lines by IFN-gamma before and after treatment and by
IFN-alpha after treatment. J Interferon Cytokine Res 25:
684–693
24. Misinzo G, Delputte PL, Meerts P, Lefebvre DJ,
Nauwynck HJ (2006) Porcine circovirus 2 uses heparan
sulfate and chondroitin sulfate B glycosaminoglycans
as receptors for its attachment to host cells. J Virol 80:
3487–3494
25. Misinzo G, Delputte PL, Nauwynck HJ (2007)
Inhibition of endosomal-lysosomal system acidification
enhances porcine circovirus 2 infection of porcine epi-
thelial cells. J Virol, doi: 10.1128=JVI.01229-07
26. Mollenhauer HH, Morre DJ, Rowe LD (1990) Alter-
ation of intracellular traffic by monensin: mechanism,
specificity and relationship to toxicity. Biochim Biophys
Acta 1031: 225–246
27. Nayar GP, Hamel A, Lin L (1997) Detection and
characterization of porcine circovirus associated with
postweaning multisystemic wasting syndrome in pigs.
Can Vet J 38: 385–386
28. O’Connor B, Gauvreau H, West K, Bogdan J, Ayroud
M, Clark EG, Konoby C, Allan G, Ellis JA (2001)
Multiple porcine circovirus 2-associated abortions and
reproductive failure in a multisite swine production unit.
Can Vet J 42: 551–553
29. Pensaert MB, Sanchez RE Jr, Ladekjaer-Mikkelsen AS,
Allan GM, Nauwynck HJ (2004) Viremia and effect of fe-
tal infection with porcine viruses with special reference to
porcine circovirus 2 infection. Vet Microbiol 98: 175–183
30. Pringle CR (1999) Virus taxonomy at The XIth Inter-
national Congress of Virology, Sydney, Australia. Arch
Virol 144: 2065–2070
31. Rosell C, Segales J, Ramos-Vara JA, Folch JM,
Rodriguez-Arrioja GM, Duran CO, Balasch M, Plana-
Duran J, Domingo M (2000) Identification of porcine
circovirus in tissues of pigs with porcine dermatitis and
nephropathy syndrome. Vet Rec 146: 40–43
32. Rovira A, Balasch M, Segales J, Garcia L, Plana-Duran
J, Rosell C, Ellerbrok H, Mankertz A, Domingo M
(2002) Experimental inoculation of conventional pigs
with porcine reproductive and respiratory syndrome
virus and porcine circovirus 2. J Virol 76: 3232–3239
33. Sanchez RE Jr, Nauwynck HJ, McNeilly F, Allan GM,
Pensaert MB (2001) Porcine circovirus 2 infection in
Enhancement of PCV2 production in PK-15 cells 341
swine foetuses inoculated at different stages of gesta-
tion. Vet Microbiol 83: 169–176
34. Sanchez RE Jr, Meerts P, Nauwynck HJ, Pensaert MB
(2003) Change of porcine circovirus 2 target cells in
pigs during development from fetal to early postnatal
life. Vet Microbiol 95: 15–25
35. Saoulidis K, Kyriakis SC, Kennedy S, Lekkas S,
Miliotis Ch C, Allan G, Balkamos GC, Papoutsis PA
(2002) First report of post-weaning multisystemic wast-
ing syndrome and porcine dermatitis and nephropathy
syndrome in pigs in Greece. J Vet Med B Infect Dis Vet
Public Health 49: 202–205
36. Tartakoff AM, Vassalli P (1977) Plasma cell immuno-
globulin secretion: arrest is accompanied by alterations
of the golgi complex. J Exp Med 146: 1332–1345
37. Thomson J, Smith B, Allan G, McNeilly F, McVicar C
(2000) PDNS, PMWS and porcine circovirus type 2
in Scotland. Porcine dermatitis and nephropathy syn-
drome. Post-weaning multisystemic wasting syndrome.
Vet Rec 146: 651–652
38. Wattrang E, McNeilly F, Allan GM, Greko C, Fossum
C, Wallgren P (2002) Exudative epidermitis and porcine
circovirus-2 infection in a Swedish SPF-herd. Vet
Microbiol 86: 281–293
342 G. Misinzo et al.: Enhancement of PCV2 production in PK-15 cells
